Seeing Is Believing
Currently out of the existing stock ratings of Oren Livnat, 15 are a HOLD (6.3%), 223 are a BUY (93.7%).
Analyst Oren Livnat, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 36.7% that have a potential upside of 49.72% achieved within 255 days.
Oren Livnat’s has documented 437 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PCRX, Pacira Pharmaceuticals at 08-Apr-2025.
Analyst best performing recommendations are on MNLO (MENLO THERAPEUTICS).
The best stock recommendation documented was for VYNE (VYNE THERAPEUTICS) at 5/12/2020. The price target of $180 was fulfilled within 16 days with a profit of $49.68 (38.12%) receiving and performance score of 23.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$32
$5.55 (20.98%)
$32
29 days ago
(08-Apr-2025)
4/20 (20%)
$5.73 (21.81%)
496
Buy
$65
$38.55 (145.75%)
$70
29 days ago
(08-Apr-2025)
13/29 (44.83%)
$38.73 (147.43%)
233
Hold
$18
$-8.45 (-31.95%)
$18
3 months 23 days ago
(14-Jan-2025)
1/11 (9.09%)
$-2.55 (-12.41%)
11
Hold
$17
$-9.45 (-35.73%)
$25
5 months 25 days ago
(12-Nov-2024)
4/12 (33.33%)
$0.2 (1.19%)
270
Buy
$18
$-8.45 (-31.95%)
$30
7 months 13 days ago
(24-Sep-2024)
1/4 (25%)
$3.74 (26.23%)
71
Which stock is Oren Livnat is most bullish on?
Which stock is Oren Livnat is most reserved on?
What Year was the first public recommendation made by Oren Livnat?